New York, NY · Founded 2020 · Privately Held (backing)
Developer of clinical-stage drugs designed for the treatment of autoimmune, cancer, and other serious diseases. Graviton BioScience is based in New York, NY and was founded in 2020. It was valued at $264 million at its early-stage round in Feb 2024, the last priced event on record. It has raised $93.3 million across 4 recorded rounds; the latest was a $25 million early-stage round in Jan 2024.
PMV mark · valuation
$264.0M
Oct 2026
Priced at
its early-stage round
Feb 2024
Total raised
$93.3M
Last round
Early Stage VC
Jan 2024
Team — not yet on record
No current team members for Graviton BioScience are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Graviton BioScience with a free account
·Watch Graviton BioScience: the Monday email on marks, rounds and moves
